Anúncio
Anúncio

RXST

RXST logo

RxSight, Inc. Common Stock

8.86
USD
Patrocinado
-0.71
-7.47%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

9.08

+0.22
+2.54%

Relatórios de Lucros RXST

Rácio de surpresa positiva

RXST separação 16 de 18 últimas estimativas.

89%

Próximo Relatório

Data do Próximo Relatório
26 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$28.08M
/
-$0.34
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-7.44%
/
+41.67%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-30.17%
/
+126.67%

RxSight, Inc. Common Stock earnings per share and revenue

On 05 de nov. de 2025, RXST reported earnings of -0.24 USD per share (EPS) for Q3 25, beating the estimate of -0.38 USD, resulting in a 37.87% surprise. Revenue reached 30.34 milhão, compared to an expected 25.78 milhão, with a 17.67% difference. The market reacted with a +3.24% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analistas forecast an EPS of -0.34 USD, with revenue projected to reach 28.08 milhão USD, implying an aumentar of 41.67% EPS, and diminuir of -7.44% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06 de jan. de 2026 Para Q2 26
Estimativa
-$0.10
Real
$0.00
Surpresa
+100.00%
FAQ
For Q3 2025, RxSight, Inc. Common Stock reported EPS of -$0.24, beating estimates by 37.87%, and revenue of $30.34M, 17.67% above expectations.
The stock price moved up 3.24%, changed from $8.34 before the earnings release to $8.61 the day after.
The next earning report is scheduled for 26 de fev. de 2026.
Based on 13 analistas, RxSight, Inc. Common Stock is expected to report EPS of -$0.34 and revenue of $28.08M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio